World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
96
Citations
35430
World Ranking
9623
National Ranking
936

Robert Huddart publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Robert Huddart sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 616 publications — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Robert Huddart D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Robert Huddart sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 96 D-Index — 53rd percentile

53% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Robert Huddart is affiliated with the Institute of Cancer Research in the United Kingdom. Their research primarily spans the field of Medicine, with specific focus across several subfields including Surgery, Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, and Molecular Biology.

The key topics of their work encompass Bladder and Urothelial Cancer Treatments, Testicular Diseases and Treatments, Urinary and Genital Oncology Studies, Sarcoma Diagnosis and Treatment, Advanced Radiotherapy Techniques, Cancer Immunotherapy and Biomarkers, and Neuroblastoma Research and Treatments.

Frequent collaborators in Robert Huddart's research include:

  • S. Hafeez
  • Emma Hall
  • H. McNair
  • Yohann Loriot
  • Ananya Choudhury

Their publications often appear in the following venues:

  • Journal of Clinical Oncology
  • Annals of Oncology
  • Radiotherapy and Oncology
  • Clinical Oncology
  • Faculty Opinions - Post-Publication Peer Review of the Biomedical Literature

Some of their recent papers include:

  • Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up, 2021, Annals of Oncology
  • Erdafitinib or Chemotherapy in Advanced or Metastatic Urothelial Carcinoma, 2023, New England Journal of Medicine
  • Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium, 2021, Journal of Clinical Oncology
  • Testicular seminoma and non-seminoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up, 2022, Annals of Oncology
  • Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium, 2021, Journal of Clinical Oncology

Best Publications

  • Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma

    Y. Loriot;A. Necchi;S. H. Park;J. Garcia-Donas

  • Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial

    David P Dearnaley;Matthew R Sydes;John D Graham;Edwin G Aird

  • Multiple newly identified loci associated with prostate cancer susceptibility.

    Rosalind A Eeles;Rosalind A Eeles;Zsofia Kote-Jarai;Graham G Giles;Graham G Giles;Ali Amin Al Olama

  • Radiotherapy with or without Chemotherapy in muscle-invasive bladder cancer

    Nicholas D. James;Syed A. Hussain;Peter Jenkins;Jean Tremlett

  • European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I

    Susanne Krege;Jörg Beyer;Rainer Souchon;Peter Albers

  • Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array

    Rosalind A. Eeles;Ali Amin Al Olama;Sara Benlloch;Edward J. Saunders

  • European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG)

    H. J. Schmoll;R. Souchon;S. Krege;P. Albers

  • Cardiovascular Disease as a Long-Term Complication of Treatment for Testicular Cancer

    R.A. Huddart;A. Norman;M. Shahidi;A. Horwich

  • The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20.

    T.J. Postma;N.K. Aaronson;J.J. Heimans;M.J. Muller

  • Stereotactic body radiotherapy for oligometastases.

    Alison C Tree;Vincent S Khoo;Rosalind A Eeles;Merina Ahmed

  • Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System).

    Valeria Panebianco;Yoshifumi Narumi;Ersan Altun;Bernard H. Bochner

  • Identification of seven new prostate cancer susceptibility loci through a genome-wide association study

    Rosalind A. Eeles;Zsofia Kote-Jarai;Ali Amin Al Olama;Graham G. Giles;Graham G. Giles

  • Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial

    David P Dearnaley;David P Dearnaley;Gordana Jovic;Isabel Syndikus;Vincent Khoo

  • Testicular germ-cell cancer

    Alan Horwich;Janet Shipley;Robert Huddart

  • Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial.

    Thomas Powles;Thomas Powles;Tibor Csőszi;Mustafa Özgüroğlu;Nobuaki Matsubara

  • Antibacterial Prophylaxis after Chemotherapy for Solid Tumors and Lymphomas

    Michael Cullen;Neil Steven;Lucinda Billingham;Claire Gaunt

  • Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours

    J. M. O’Sullivan;R. A. Huddart;A. R. Norman;J. Nicholls

  • Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study.

    Roy Vergis;Catherine M Corbishley;Andrew R Norman;Jaclyn Bartlett

  • Variants near DMRT1 , TERT and ATF7IP are associated with testicular germ cell cancer

    Clare Turnbull;Elizabeth A Rapley;Sheila Seal;David Pernet

  • A genome-wide association study of testicular germ cell tumor.

    Elizabeth A Rapley;Clare Turnbull;Ali Amin Al Olama;Emmanouil T Dermitzakis

Frequent Co-Authors

Alan Horwich
Alan Horwich Royal Marsden NHS Foundation Trust
David P. Dearnaley
David P. Dearnaley Institute of Cancer Research
Chris Parker
Chris Parker Institute of Cancer Research
Vincent Khoo
Vincent Khoo Royal Marsden NHS Foundation Trust
A. R. Norman
A. R. Norman Royal Marsden NHS Foundation Trust
Rosalind A. Eeles
Rosalind A. Eeles Institute of Cancer Research
Nicholas D. James
Nicholas D. James Institute of Cancer Research
Douglas F. Easton
Douglas F. Easton University of Cambridge
Janet Shipley
Janet Shipley Institute of Cancer Research
Sophie D. Fosså
Sophie D. Fosså Oslo University Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in medicine opens up a wide range of online degree options that complement or provide alternative paths to traditional medical school. For those interested in specialized nursing, exploring pmhnp online programs is a flexible way to become a Psychiatric Mental Health Nurse Practitioner, a growing field within mental health.

If you're drawn to the broader healthcare system, a health care administration online degree can prepare you to lead hospitals, clinics, or other medical facilities. These programs are a great fit for those interested in the business and organizational aspects of healthcare.

For graduate-level advancement, check out the cheapest mha programs online to find cost-effective ways to deepen your knowledge in healthcare administration.

Finally, nurses aiming for the highest credentials might be interested in the least expensive dnp programs, which offer doctoral-level training affordably and conveniently online.

Best Scientists Citing Robert Huddart

Trending Scientists

Recently Published Articles